SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-146059
Filing Date
2013-04-08
Accepted
2013-04-08 16:48:02
Documents
14
Period of Report
2013-05-23
Effectiveness Date
2013-04-08

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A d494052ddef14a.htm DEF 14A 632135
2 GRAPHIC g494052g15t21.jpg GRAPHIC 22286
3 GRAPHIC g494052g27u30.jpg GRAPHIC 19433
4 GRAPHIC g494052g29r18.jpg GRAPHIC 31947
5 GRAPHIC g494052g49d35.jpg GRAPHIC 9005
6 GRAPHIC g494052g52x79.jpg GRAPHIC 16028
7 GRAPHIC g494052g56p60.jpg GRAPHIC 4844
8 GRAPHIC g494052g80r63.jpg GRAPHIC 41461
9 GRAPHIC g494052g84m01.jpg GRAPHIC 32033
10 GRAPHIC g494052g84n31.jpg GRAPHIC 32092
11 GRAPHIC g494052g88c23.jpg GRAPHIC 32387
12 GRAPHIC g494052g96g17.jpg GRAPHIC 20899
13 GRAPHIC g494052img1.jpg GRAPHIC 150218
14 GRAPHIC g494052img2.jpg GRAPHIC 120304
  Complete submission text file 0001193125-13-146059.txt   1369383
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33137 | Film No.: 13748796
SIC: 2834 Pharmaceutical Preparations